9
Disclosures
Jan 29, 2026 — Feb 19, 2026
Date Range
GROWTH
Market Segment
Pharmaceutical
Sector
Disclosures
| Date | Type | Headline | |
|---|---|---|---|
| Feb 19 | Other | Carna Biosciences Announces New Board Members and Audit Committee Changes | |
| Feb 19 | Governance | Carna Biosciences,Inc. Announces Amendment to Articles of Incorporation | |
| Feb 17 | M&A | Carna Biosciences,Inc. Board Supports Tender Offer, Recommends Shareholders Tender | |
| Feb 10 | Earnings | Carna Biosciences,Inc. Announces Business Plan | |
| Feb 10 | Earnings | Carna Biosciences,Inc. Reports FY2025 Earnings Presentation: Revenue of 636 million | |
| Feb 10 | Earnings | Carna Biosciences,Inc. Reports FY25 Revenue of 579 million, Down 9% | |
| Jan 30 | Equity Issuance | Carna Biosciences Corrects Bond Repurchase Date in Previous Announcement | |
| Jan 29 | Equity Issuance | Issues 76,983 Convertible Bonds with Price Adjustment Clause | |
| Jan 29 | M&A | Carna Biosciences,Inc. Board Supports Tender Offer, Recommends Shareholders Tender |
Disclosure Types
Earnings: 3 M&A: 2 Equity Issuance: 2 Other: 1 Governance: 1